Biohelix

Biohelix

Biohelix is to improve the quality of healthcare through the development of simple molecular diagnostic tests.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD15m (Public information from May 2013)
Beverly Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound

$10.0m

Valuation: $10.0m

Acquisition
Total Funding-

Recent News about Biohelix

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.